Ocampo, Lefrizer V.
HRN: 23-93-92 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/20/2023
CEFUROXIME 750MG (VIAL)
10/20/2023
10/27/2023
IV
750mg
Q8H
UTI
Checking Final Appropriateness
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes